Journal
MOLECULAR METABOLISM
Volume 4, Issue 4, Pages 287-298Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.molmet.2015.01.011
Keywords
Fto; Leptin resistance; High-fat diet; NF kappa B; TRIP4; Hypothalamus; SOCS3
Categories
Funding
- MRC [G0900554, G0600717, MC_UU_12012/5, MC_UU_12012/1] Funding Source: UKRI
- Medical Research Council [G0600717B, MC_UU_12012/5/B, G0900554, MC_UU_12012/5, G0600717, MC_UU_12012/1] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0507-10380] Funding Source: researchfish
- Medical Research Council [G0600717, MC_UU_12012/5, G0900554, MC_UU_12012/1] Funding Source: Medline
- Wellcome Trust [100574] Funding Source: Medline
Ask authors/readers for more resources
Objective: Loss of function FTO mutations significantly impact body composition in humans and mice, with Fto-deficient mice reported to resist the development of obesity in response to a high-fat diet (HFD). We aimed to further explore the interactions between FTO and HFD and determine if FTO can influence the adverse metabolic consequence of HFD. Methods: We studied mice deficient in FTO in two well validated models of leptin resistance (HFD feeding and central palmitate injection) to determine how Fto genotype may influence the action of leptin. Using transcriptomic analysis of hypothalamic tissue to identify relevant pathways affected by the loss of Fto, we combined data from co-immunoprecipitation, yeast 2-hybrid and luciferase reporter assays to identify mechanisms through which FTO can influence the development of leptin resistant states. Results: Mice deficient in Fto significantly increased their fat mass in response to HFD. Fto(+/-) and Fto(+/-) mice remained sensitive to the anorexigenic effects of leptin, both after exposure to a HFD or after acute central application of palmitate. Genes encoding components of the NF kappa B signalling pathway were down-regulated in the hypothalami of Fto-deficient mice following a HFD. When this pathway was reactivated in Fto-deficient mice with a single low central dose of TNF alpha, the mice became less sensitive to the effect of leptin. We identified a transcriptional coactivator of NF kappa B, TRIP4, as a binding partner of FTO and a molecule that is required for TRIP4 dependent transactivation of NF kappa B. Conclusions: Our study demonstrates that, independent of body weight, Fto influences the metabolic outcomes of a HFD through alteration of hypothalamic NF kappa B signalling. This supports the notion that pharmacological modulation of FTO activity might have the potential for therapeutic benefit in improving leptin sensitivity, in a manner that is influenced by the nutritional environment. (C) 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available